A Phase I Study of R115777 (Zarnestra) in Combination With Induction Chemotherapy in Patients With Newly Diagnosed, High Risk Acute Myeloid Leukemia

Trial Profile

A Phase I Study of R115777 (Zarnestra) in Combination With Induction Chemotherapy in Patients With Newly Diagnosed, High Risk Acute Myeloid Leukemia

Discontinued
Phase of Trial: Phase I

Latest Information Update: 02 May 2013

At a glance

  • Drugs Tipifarnib (Primary) ; Cytarabine; Daunorubicin; Etoposide
  • Indications Acute myeloid leukaemia
  • Focus Adverse reactions
  • Most Recent Events

    • 21 Feb 2008 Actual end date (Dec 2007) added as reported by ClinicalTrials.gov.
    • 21 Feb 2008 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 04 Jan 2008 Status change from recruiting to completed, from nct record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top